Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 18;11(4):1087.
doi: 10.3390/jcm11041087.

Effect of Transcutaneous Vagus Nerve Stimulation in Erosive Hand Osteoarthritis: Results from a Pilot Trial

Affiliations

Effect of Transcutaneous Vagus Nerve Stimulation in Erosive Hand Osteoarthritis: Results from a Pilot Trial

Alice Courties et al. J Clin Med. .

Abstract

Beyond its effect on vegetative functions, the activation of the vagus nerve inhibits inflammation and reduces pain signaling. The aim of this open-label pilot study was to determine the efficacy and tolerance of transcutaneous auricular VNS (taVNS) on erosive hand osteoarthritis (EHOA) symptoms. Symptomatic EHOA patients with hand pain VAS ≥ 40/100 mm and ≥1 interphalangeal swollen joint(s) were included. The taVNS was performed for 4 weeks using an auricular electrode applied one hour per day and connected to a TENS device with pre-established settings. Clinical efficacy was evaluated by changes between baseline and at 4 weeks with hand pain VAS and the functional index FIHOA score, using a Wilcoxon t-test. The treatment tolerance was also evaluated. Eighteen patients (median age 69 years old, 83% women) were analyzed. At baseline, hand pain VAS was 60 mm [IQR 50; 78.2] and FIHOA 15 [10.7; 20.2]. After 4 weeks, taVNS significantly reduced hand pain VAS, with a median decrease of 23.5 mm [7.7; 37.2] (p = 0.001), as well as FIHOA, with a median decrease of 2 points [0.75; 5.2] (p = 0.01). No serious adverse events were reported. One patient stopped taVNS because of auricular discomfort. This first proof-of-concept trial indicated that taVNS is feasible and may decrease joint inflammation and clinical symptoms in EHOA, arguing for a randomized controlled study versus sham stimulation.

Keywords: erosive hand osteoarthritis; function; inflammation; pain; vagus nerve stimulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interest.

Figures

Figure 1
Figure 1
TaVNS device kit. Left to right: Description of the cymba concha, a picture of the auricular electrode applied on the cymba concha, a TENSeco2 device, and the conductive gel (copyright Schwa-Medico).
Figure 2
Figure 2
Effect of taVNS on EHOA symptoms. Evolution of (A) hand pain VAS on a 0–100 mm scale, (B) function evaluated by FIHOA, (C) number of painful joints (0–30), (D) number of swollen joints (0–30) of erosive hand osteoarthritis for each of the eighteen patients. Paired, non-parametric Wilcoxon t-test was used. Abbreviations: VAS, visual analog scale; FIHOA, Functional Index for Hand Osteoarthritis.

Similar articles

Cited by

References

    1. Hodkinson B., Maheu E., Michon M., Carrat F., Berenbaum F. Assessment and Determinants of Aesthetic Discomfort in Hand Osteoarthritis. Ann. Rheum. Dis. 2012;71:45–49. doi: 10.1136/ard.2011.153965. - DOI - PubMed
    1. Haugen I.K., Englund M., Aliabadi P., Niu J., Clancy M., Kvien T.K., Felson D.T. Prevalence, Incidence and Progression of Hand Osteoarthritis in the General Population: The Framingham Osteoarthritis Study. Ann. Rheum. Dis. 2011;70:1581–1586. doi: 10.1136/ard.2011.150078. - DOI - PMC - PubMed
    1. Bijsterbosch J., Watt I., Meulenbelt I., Rosendaal F.R., Huizinga T.W.J., Kloppenburg M. Clinical Burden of Erosive Hand Osteoarthritis and Its Relationship to Nodes. Ann. Rheum. Dis. 2010;69:1784–1788. doi: 10.1136/ard.2009.125435. - DOI - PubMed
    1. Kloppenburg M., Kroon F.P., Blanco F.J., Doherty M., Dziedzic K.S., Greibrokk E., Haugen I.K., Herrero-Beaumont G., Jonsson H., Kjeken I., et al. 2018 Update of the EULAR Recommendations for the Management of Hand Osteoarthritis. Ann. Rheum. Dis. 2019;78:16–24. doi: 10.1136/annrheumdis-2018-213826. - DOI - PubMed
    1. Richette P., Latourte A., Sellam J., Wendling D., Piperno M., Goupille P., Pers Y.-M., Eymard F., Ottaviani S., Ornetti P., et al. Efficacy of Tocilizumab in Patients with Hand Osteoarthritis: Double Blind, Randomised, Placebo-Controlled, Multicentre Trial. Ann. Rheum. Dis. 2020;80:349–355. doi: 10.1136/annrheumdis-2020-218547. - DOI - PubMed

LinkOut - more resources